Summary
This Form 8-K filing from Alnylam Pharmaceuticals, Inc. (ALNY) on March 28, 2012, primarily details the establishment of the company's 2012 Annual Incentive Program. This program outlines the framework for awarding cash bonuses to all regular employees, including executive officers, based on the achievement of specific corporate and individual performance goals for the fiscal year 2012. The core of the program involves a "Bonus Pool" that is contingent on the Company's overall performance against established corporate goals, with a minimum threshold required for any bonuses to be paid. Executive officers' bonuses are solely tied to corporate performance, while other employees' bonuses consider both corporate and individual objectives. The determination and payout of these bonuses are scheduled for December 2012 and January 2013, respectively.
Key Highlights
- 1Alnylam Pharmaceuticals has established a 2012 Annual Incentive Program for all regular employees, including executive officers.
- 2The program allows for annual cash bonuses to be awarded based on the achievement of pre-defined corporate and individual performance goals for 2012.
- 3Executive officers' bonuses are exclusively tied to the achievement of corporate goals.
- 4A minimum corporate performance threshold (50% of target) must be met for any bonuses to be paid under the plan.
- 5Target award percentages for bonuses are set as a percentage of base salary, with the CEO having a target of 60% and varying percentages for other levels down to 7.5% for all other regular employees.
- 6The "Bonus Pool" is calculated based on aggregated target awards and a modifier reflecting corporate performance.
- 7Bonus determinations and payouts are expected in December 2012 and January 2013, respectively.